Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reading comprehension is a complex cognitive process involving the extraction of meaning from written text through integrated skills like decoding (sounding out words), vocabulary recognition, syntax understanding, and higher-order thinking such as inference and summarization. It relies on brain networks including left inferior frontal gyrus (LIFG) and left middle temporal gyrus (LMTG) for amodal language comprehension, with modality-specific activation in left inferior occipital cortex (fusiform gyrus) for visual word processing. Poor reading comprehension often stems from deficits in word-level processing or neurobiological markers like reduced left temporoparietal and occipitotemporal (OT) activation, as seen in dyslexia. Individual differences, such as working memory capacity, influence brain lateralization, with lower-capacity readers showing right-hemisphere spillover. While not a molecular target like receptors or enzymes, impairments link to developmental disorders, and interventions aim to strengthen left-hemisphere circuits for fluent processing. No drugs directly target it; focus remains on cognitive training and education.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reading comprehension.